Advertisement

Topics

Reset Therapeutics Company Profile

03:30 EDT 24th June 2018 | BioPortfolio

Reset Therapeutics is a privately held biopharmaceutical company focused on harnessing the power of the body’s internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications. Molecular clocks are the foundation of the body’s circadian system, which synchronizes many biological processes with cycles of light, activity, and nutrient status. Founded in 2008 by leaders in the field of molecular clock biology and Bay City Capital, the company has unparalleled expertise and intellectual property related to molecular clocks and the roles that they play in health and disease.


News Articles [809 Associated News Articles listed on BioPortfolio]

Sandoz to commercialize Pear's reSET digital therapeutics to combat substance abuse

Sandoz International GMBH will lead the commercialization of Pear Therapeutics Inc.'s reSET for substance use disorder (SUD) and reSET-O for opioid use disorder (OUD).

PEAR Therapeutics to Participate in BIO CEO & Investor Conference and LEERINK Partners 7th Annual Global Healthcare Conference

PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO of PEAR Therapeutics, will present a company ...

Digital therapies start-up Pear Therapeutics closes $20mm round

Prescription digital therapeutics start-up Pear Therapeutics Inc. closed a $20mm private equity financing, assumed to be its Series A round, co-led by 5AM Ventures, Arboretum Ventures, and Jazz Ventur...

PEAR Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO of PEAR Therapeutics, will present at the ann...

Pear Therapeutics to Present at UBS Global Healthcare Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Ope...

Pear Therapeutics to Present at Jefferies 2018 Healthcare Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Jefferies 2018 Hea...

Pear Therapeutics to Present at 38th Annual Cowen Health Care Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Cowen Health Care ...

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

Sandoz to lead global launch of reSET® and reSET-O™; Pear to provide ongoing development and patient services hub Deal combines Pear’s leadership in prescriptio...

PubMed Articles [462 Associated PubMed Articles listed on BioPortfolio]

Compliance-Free, Digital SET and Analog RESET Synaptic Characteristics of Sub-Tantalum Oxide Based Neuromorphic Device.

A two terminal semiconducting device like a memristor is indispensable to emulate the function of synapse in the working memory. The analog switching characteristics of memristor play a vital role in ...

Period-adding bifurcation and chaos in a hybrid Hindmarsh-Rose model.

Recently, the hybrid neuron models which combine the basic neuron models with impulsive effect(the state reset process) had been proposed, however, the preset value and the reset value of membrane pot...

Let's Hit the Reset Button.

Scaling Effect on Silicon Nitride Memristor with Highly Doped Si Substrate.

A feasible approach is reported to reduce the switching current and increase the nonlinearity in a complementary metal-oxide-semiconductor (CMOS)-compatible Ti/SiN /p -Si memristor by simply reducing ...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Clinical Trials [158 Associated Clinical Trials listed on BioPortfolio]

Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Type 1 diabetes is an autoimmune disease characterized by destruction of pancreatic beta-cells, resulting in absolute deficiency of insulin. Presently there is no known cure. Our proposed...

Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus

There are many treatments for chronic tinnitus that have been claimed, with varying degrees of statistical reliability. None of those treatments can eradicate the tinnitus completely. Some...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1240 Associated Companies listed on BioPortfolio]

Reset Therapeutics, Inc.

Reset, a discovery-stage biopharma company co-founded by leaders in the field of circadian biology and Bay City Capital, is developing first-in-class approaches to treating diseas...

Reset Therapeutics

Reset Therapeutics is a privately held biopharmaceutical company focused on harnessing the power of the body’s internal molecular clocks to discover, develop, and commerciali...

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

American Institute of Chemical Engineers (AIChE)

AIChE is enhancing its website and database security policies which require that the security features currently in place be updated. Registered passwords will be reset on Sunday, July 8. Registered ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Reset Therapeutics" on BioPortfolio

We have published hundreds of Reset Therapeutics news stories on BioPortfolio along with dozens of Reset Therapeutics Clinical Trials and PubMed Articles about Reset Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reset Therapeutics Companies in our database. You can also find out about relevant Reset Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record